Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

Compare

10.86

-0.01 (-0.09%)

At close: Feb 12, 2026, 4:00 PM EST

10.71

-0.15 (-1.38%)

Pre-market: Feb 13, 2026, 7:06 AM EST

Fulcrum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	47.08	58.21	25.56	35.1	35.41	57.05
Short-Term Investments	153.57	182.81	210.66	167.82	182.75	55.86
Cash & Short-Term Investments	200.65	241.02	236.22	202.92	218.16	112.91
Cash Growth	-22.00%	2.03%	16.41%	-6.99%	93.21%	16.75%
Accounts Receivable	-	2.1	0.54	0.23	3.64	2.53
Other Receivables	0.93	1.25	1.71	0.85	0.47	0.18
Receivables	0.93	3.34	2.25	1.08	4.11	2.71
Prepaid Expenses	4.28	5.56	3.73	3.52	3.73	3.82
Other Current Assets	-	-	-	-	-	0.07
Total Current Assets	205.86	249.92	242.2	207.52	226	119.51
Property, Plant & Equipment	7.79	9.58	12.39	15.97	7.37	8.4
Other Long-Term Assets	1.21	1.21	3.1	3.2	1.63	1.67
Total Assets	214.86	260.72	257.69	226.69	235	129.58
Accounts Payable	2.86	1.16	2.76	3.64	4.79	4.08
Accrued Expenses	6.19	7.23	8.33	9.45	9.16	7.21
Current Portion of Leases	2.35	2.19	2.19	2.6	-	0.02
Current Unearned Revenue	-	-	-	0.93	4.71	14.91
Other Current Liabilities	0.24	0.46	0.4	0.11	0.54	0.51
Total Current Liabilities	11.63	11.04	13.68	16.73	19.2	26.73
Long-Term Leases	4.66	6.44	8.63	10.82	-	-
Long-Term Unearned Revenue	-	-	-	-	-	2.97
Other Long-Term Liabilities	0.2	0.2	0.2	0.2	4.26	4.7
Total Liabilities	16.49	17.68	22.5	27.74	23.46	34.4
Common Stock	0.05	0.05	0.06	0.05	0.04	0.03
Additional Paid-In Capital	772.02	762.25	744.94	612.03	514.36	316.78
Retained Earnings	-573.94	-519.4	-509.67	-412.34	-302.47	-221.62
Comprehensive Income & Other	0.24	0.13	-0.14	-0.8	-0.4	-0
Total Common Equity	198.37	243.03	235.19	198.94	211.54	95.18
Shareholders' Equity	198.37	243.03	235.19	198.94	211.54	95.18
Total Liabilities & Equity	214.86	260.72	257.69	226.69	235	129.58
Total Debt	7.01	8.63	10.82	13.42	-	0.02
Net Cash (Debt)	193.63	232.39	225.4	189.5	218.16	112.9
Net Cash Growth	-21.95%	3.10%	18.95%	-13.14%	93.24%	16.79%
Net Cash Per Share	3.11	3.75	3.68	4.21	6.17	4.45
Filing Date Shares Outstanding	54.12	53.98	61.94	61.76	40.63	32.55
Total Common Shares Outstanding	54.11	53.97	61.92	52.1	40.63	27.94
Working Capital	194.23	238.88	228.52	190.79	206.8	92.79
Book Value Per Share	3.67	4.50	3.80	3.82	5.21	3.41
Tangible Book Value	198.37	243.03	235.19	198.94	211.54	95.18
Tangible Book Value Per Share	3.67	4.50	3.80	3.82	5.21	3.41
Machinery	11.15	10.84	10.68	10.24	9.15	7.84
Construction In Progress	-	-	-	0.03	-	0.26
Leasehold Improvements	7.12	7.12	7.1	7.1	6.29	6.21

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q